1. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells
   Liang Liu et al, 2017, Pathology - Research and Practice CrossRef
2. ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer
   David Vrana et al, 2018, IJMS CrossRef
3. Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate.
   Lei Wang et al, 2018, Pathol Res Pract CrossRef
4. Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
   Ning Ji et al, 2018, Cancer Letters CrossRef
5. Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
   Ning Ji et al, 2018, Biochemical Pharmacology CrossRef
6. VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
   Ning Ji et al, 2018, Front. Pharmacol. CrossRef
7. Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
   Li Chen et al, 2019, RSC Adv. CrossRef
8. The role of ABC transporters in ovarian cancer progression and chemoresistance.
   M P Ween et al, 2015, Crit Rev Oncol Hematol CrossRef
9. Prognostic impact of membranous ATP-binding cassette Sub-family G member 2 expression in patients with colorectal carcinoma after surgical resection
   Donghoon Kang et al, 2015, Cancer Biology & Therapy CrossRef
10. Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer
    P. S. Thakur et al, 2016, J Cancer Res Clin Oncol CrossRef
11. Targeting Chemotherapy Resistance in Glioblastoma Through Modulation of ABC Transporters
    Amanda Tivnan, 2016 CrossRef
12. CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2
    Lejia Xu et al, 2020, Molecular Therapy - Oncolytics CrossRef
13. High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer
    Guobo Du et al, 2020, CCHTS CrossRef
14. Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells
    Yi-Dong Li et al, 2020, Front. Oncol. CrossRef
15. Suppression of Esophageal Cancer Stem-like Cells by SNX-2112 Is Enhanced by STAT3 Silencing
    Dan-dan Xu et al, 2020, Front. Pharmacol. CrossRef
16. Multidrug efflux transporter ABCG2: expression and regulation.
    Samiksha Kukal et al, 2021, Cell Mol Life Sci CrossRef
17. Assessment of Gene Expression Level of ATP Binding Cassette G Member 2 (ABCG2) Transporter in Newly Diagnosed Breast Cancer Patients Receiving Adjuvant Chemotherapy
    null Shaimaa A. Soliman et al, 2019, J. Can. Res. Updates CrossRef
18. The critical role of circular RNAs in drug resistance in gastrointestinal cancers
    Sadra Samavarchi Tehrani et al, 2023, Med Oncol CrossRef
19. Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?
    Mostafa Vaghari-Tabari et al, 2024, Biol Trace Elem Res CrossRef
20. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers
    Mostafa Vaghari-Tabari et al, 2024, Biomedicine & Pharmacotherapy CrossRef
21. The association of ABC proteins with multidrug resistance in cancer
    Andrezza Viviany Lourenço Marques et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef